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Background: Exercise-induced bronchoconstriction (EIB) is highly prevalent in athletes and 
impacts on their health and performance. The gold-standard means for diagnosing EIB is 
indirect bronchoprovocation testing, however the repeatability of this methodology is not 
established. Aims and objectives: To evaluate the short-term test-retest repeatability of 
eucapnic voluntary hyperpnea (EVH). Methods: Twenty-five recreationally active men 
(n=21) and women (n=4) were recruited. Participants were required to attend on two separate 
occasions separated by a period of fourteen days. Participants performed spirometry before 
and following (at 3,5,10 and 15 mins) an EVH challenge (6 minutes at 85% maximum 
voluntary ventilation). Difference in forced expiratory volume in one second (FEV1) between 
visits was analysed using Bland-Altman methodology. Results: 22 subjects completed both 
visits (n=3 excluded - unwell), mean (SD) age 25 (±4) yrs, FEV1 102 (±8.6) % predicted. 
There was no significant difference in maximum fall in FEV1 post EVH between visits 
(P>0.05), however Bland-Altman analysis revealed wide limits of agreement (-10.36-7.9%) 
for the difference in fall in FEV1 between visits. A diagnosis of EIB (>10% fall in FEV1) was 
established in two athletes at visit one whereas this increased to five athletes at visit 2. 
Importantly, only one athlete had a diagnosis of EIB confirmed at both visits. Conclusion: In 
this cohort of athletes EVH demonstrated poor repeatability over a fixed two-week period. 
The findings highlight the need for caution when considering confirming or refuting a 
diagnosis of EIB based on a solitary indirect bronchoprovocation test and a cut-off value of 
10% fall in FEV1.  
 
 
 
 
